Rosty Raykov

CIK: 0001468316

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)28 (43.8%)

Position reduction

Option Exercises (M)11 (17.2%)

Derivative conversions

Awards (A)25 (39.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENC

FENNEC PHARMACEUTICALS INC.

Discretionary Trading P&L

Holdings

Transaction History (64 total)

FENC
FENNEC PHARMACEUTICALS INC.
Sep 1, 2026
Sale(S)
Direct
10K shares at avg. $12.11$121K
FENC
FENNEC PHARMACEUTICALS INC.
Aug 31, 2026
Award(A)
Direct
2.8K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Aug 3, 2026
Sale(S)
Direct
10K shares at avg. $9.58$96K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 31, 2026
Award(A)
Direct
2.8K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jul 1, 2026
Sale(S)
Direct
9.6K shares at avg. $10.41$100K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 1, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 1, 2026
Award(A)
Direct
2.8K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jun 1, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Jun 1, 2026
Sale(S)
Direct
9.7K shares at avg. $9.62$94K
FENC
FENNEC PHARMACEUTICALS INC.
May 31, 2026
Award(A)
Direct
2.8K shares-
FENC
FENNEC PHARMACEUTICALS INC.
May 1, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
May 1, 2026
Sale(S)
Direct
10.8K shares at avg. $6.47$70K
FENC
FENNEC PHARMACEUTICALS INC.
Apr 30, 2026
Exercise(M)
Direct
2.8K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Apr 1, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Apr 1, 2026
Sale(S)
Direct
10.9K shares at avg. $6.31$69K
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Award(A)
Direct
5.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 2, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Mar 2, 2026
Sale(S)
Direct
10.1K shares at avg. $8.36$84K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 28, 2026
Award(A)
Direct
5.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Feb 2, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 2, 2026
Sale(S)
Direct
10.3K shares at avg. $7.76$80K
FENC
FENNEC PHARMACEUTICALS INC.
Jan 31, 2026
Award(A)
Direct
5.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jan 2, 2026
Sale(S)
Direct
10.3K shares at avg. $7.60$78K
FENC
FENNEC PHARMACEUTICALS INC.
Jan 2, 2026
Exercise(M)
Direct
15.6K shares at avg. $2.45$38K
FENC
FENNEC PHARMACEUTICALS INC.
Dec 31, 2025
Award(A)
Direct
5.2K shares-

		Type	Shares	Price		Ownership
Sep 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,000	$12.11	$121,100	Direct
Aug 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,778	-	$0	Direct
Aug 3, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,000	$9.58	$95,800	Direct
Jul 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,778	-	$0	Direct
Jul 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	9,599	$10.41	$99,926	Direct
Jul 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,597	$2.45	$38,213	Direct
Jul 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,778	-	$0	Direct
Jun 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,597	$2.45	$38,213	Direct
Jun 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	9,747	$9.62	$93,766	Direct
May 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,778	-	$0	Direct
May 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,598	$2.45	$38,215	Direct
May 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,781	$6.47	$69,753	Direct
Apr 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	2,778	-	$0	Direct
Apr 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,598	$2.45	$38,215	Direct
Apr 1, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,946	$6.31	$69,069	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	5,208	-	$0	Direct
Mar 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,598	$2.45	$38,215	Direct
Mar 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,079	$8.36	$84,260	Direct
Feb 28, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	5,208	-	$0	Direct
Feb 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,598	$2.45	$38,215	Direct
Feb 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,349	$7.76	$80,308	Direct
Jan 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	5,208	-	$0	Direct
Jan 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	10,312	$7.60	$78,371	Direct
Jan 2, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	15,598	$2.45	$38,215	Direct
Dec 31, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	5,208	-	$0	Direct

1-25 of 64 transactions

About Raykov Rosty

Raykov Rosty (SEC CIK 0001468316) files insider reports with the SEC as FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 44 ownership filings by Raykov Rosty, all Form 4s, filed between Sep 4, 2024 and Sep 1, 2026. Those filings report 64 transactions, from Aug 31, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Raykov Rosty's filings is in RESEARCH TRIANGLE PARK, NC.

Recent filings by Raykov Rosty

Sep 1, 2026: Open-market sale of FENC shares (Form 4, code S).
Aug 31, 2026: Grant or award of FENC shares (Form 4, code A).
Aug 3, 2026: Open-market sale of FENC shares (Form 4, code S).
Jul 31, 2026: Grant or award of FENC shares (Form 4, code A).
Jul 1, 2026: Open-market sale of FENC shares (Form 4, code S).

Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)

Evans Terry L, Chief Commercial Officer
Sayad Pierre Sargis, Chief Medical Officer
Hackman Jeffrey S., Chief Executive Officer
Cioffi Christiana Marie, Chief Strategy Officer
Andrade Robert, CHIEF FINANCIAL OFFICER
Brughera Marco Maria, Director

How to read Form 4 transaction codes